In simple terms, our project aims to understand if different versions of a specific gene, TAS1R2, contribute to metabolic and muscle diseases. This gene is known for its role in sweet taste perception and its potential impact on sugar metabolism and muscle function. Using a large dataset from the UK Biobank that includes genetic information and health records, we aim to find connections between different types of the TAS1R2 gene and conditions related to body metabolism and muscles.
This exploration could revolutionize personalized medicine for metabolic and muscle diseases. If specific TAS1R2 gene types are linked to increased risk, custom treatments tailored to individual genetic profiles could greatly improve treatments and risk management.
